Wednesday, November 15, 2017 10:49:09 AM
Based on page 12 on yesterday's final Q report thru June 30 of this year, there is a lot of global business activity on page 12. Question is how big are the potential revenues from all of these deals if they finally come to fruition? What is interesting is all the global financing companies involved + the office in Ghana + working on providing some Canadian Nations some type of Health Care needs + a restatement that the approx. $4 mil or so debt will be taken out of the balance sheet. Would like to see a debt free balance sheet without all of those noteholders.
At least I see a few irons in the fire and hence the reason IMO for the company trying to rise from the dead at this point in time. Curious as to the company's staffing to handle all of what seems to be going on. The OTC markets site continues to list the Markham location as the primary office.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM